Alibaba Health Information Technology (ALBHF) Price & Analysis

347 Followers

ALBHF Stock Chart & Stats

$0.72

>-$0.01(-2.23%)

At close: Jan 06 4:00 PM EST

$0.72

>-$0.01(-2.23%)

Day’s Range― - ―

52-Week Range$0.39 - $0.95

Previous CloseN/A

Volume1.43K

Average Volume (3M)2.82K

Market Cap

$7.16B

Enterprise Value$41.03B

Total Cash (Recent Filing)$10.45B

Total Debt (Recent Filing)$59.56M

Price to Earnings (P/E)25.1

Beta0.85

Next Earnings

Dec 02, 2026

EPS Estimate

0.01

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.12

Shares Outstanding16,175,301,000

10 Day Avg. Volume5,704

30 Day Avg. Volume2,819

Financial Highlights & Ratios

PEG Ratio0.98

Price to Book (P/B)3.73

Price to Sales (P/S)1.94

P/FCF Ratio53.70

Enterprise Value/Market Cap5.73

Enterprise Value/Revenue1.20

Enterprise Value/Gross Profit5.00

Enterprise Value/Ebitda28.41

Forecast

1Y Price Target

$0.68

Price Target Upside-6.01% Downside

Rating ConsensusModerate Buy

Number of Analyst Covering7

EPS Forecast (FY)0.02

Revenue Forecast (FY)$4.92B

Bulls Say, Bears Say

Bulls Say

Earnings Revisions And ValuationAnalysts raised adjusted net profit estimates and increased the price target, reflecting improved earnings visibility and more favorable valuation assumptions.

Product Demand And Distribution ExpansionRapid demand for weight-loss products and plans to add temperature-sensitive SKUs along with cold-chain upgrades bolster growth potential across higher-margin categories.

Revenue OutlookCompany guidance coupled with strong online drug sales momentum supports an expectation of continued revenue expansion for 2026.

Bears Say

Price Target Downside RiskAn indicated downside to the price target signals potential valuation risk if growth or margin improvements do not meet investor expectations.

Second-half Growth Slowdown RiskCurrent guidance points to a possible deceleration in year-over-year growth in the second half of 2026, which could temper sentiment and stock performance.

Alibaba Health Information Technology News

Alibaba Health Plans Major Dividend Payout and AGM Votes on Capital and Governance

Alibaba Health Information Technology ( ($HK:0241) ) has shared an update. Alibaba Health Information Technology has called its...

7d ago

Alibaba Health Plans Bye-law Changes to Boost Dividend Flexibility and Align with HK Listing Reforms

Alibaba Health Information Technology ( ($HK:0241) ) just unveiled an update. Alibaba Health Information Technology Limited plans to...

13d ago

Alibaba Health Grants New Share Options and RSUs Under 2024 Award Scheme

Alibaba Health Information Technology ( ($HK:0241) ) has provided an announcement. Alibaba Health Information Technology has granted share-based...

28d ago

Morgan Stanley’s Alexis Yan Reiterates Sell on Alibaba Health Amid Weak Earnings Momentum and High Upfront Investment Costs

Alexis Yan, an analyst from Morgan Stanley, maintained the Sell rating on Alibaba Health Information Technology. The associated...

2M ago

Alibaba Health Delivers Strong FY2026 Profit Growth and Advances Smart Healthcare Push

The latest announcement is out from Alibaba Health Information Technology ( ($HK:0241) ). Alibaba Health Information Technology reported...

2M ago

Alibaba Health Declares Final Dividend for FY2026

Alibaba Health Information Technology ( ($HK:0241) ) has issued an announcement. Alibaba Health Information Technology has declared a...

2M ago

Alibaba Health Announces Special Dividend for FY2026

The latest update is out from Alibaba Health Information Technology ( ($HK:0241) ). Alibaba Health Information Technology Limited...

2M ago

Alibaba Health Plans Share Premium Cut to Boost Dividend Capacity

An update from Alibaba Health Information Technology ( ($HK:0241) ) is now available. Alibaba Health Information Technology plans...

2M ago

Alibaba Health Names New CFO and Executive Director as Tu Yanwu Steps Down

Alibaba Health Information Technology ( ($HK:0241) ) has provided an update. Alibaba Health Information Technology has appointed Sheng...

2M ago

Alibaba Health Reshapes Board and Committee Roles Effective May 2026

Alibaba Health Information Technology ( ($HK:0241) ) has shared an announcement. Alibaba Health Information Technology Limited has updated...

2M ago

ALBHF FAQ

What was Alibaba Health Information Technology Ltd.’s price range in the past 12 months?

Alibaba Health Information Technology Ltd. lowest stock price was $0.39 and its highest was $0.94 in the past 12 months.

What is Alibaba Health Information Technology Ltd.’s market cap?

Alibaba Health Information Technology Ltd.’s market cap is $7.16B.

When is Alibaba Health Information Technology Ltd.’s upcoming earnings report date?

Alibaba Health Information Technology Ltd.’s upcoming earnings report date is Dec 02, 2026 which is in 142 days.

How were Alibaba Health Information Technology Ltd.’s earnings last quarter?

Alibaba Health Information Technology Ltd. released its earnings results on May 14, 2026. The company reported $0.009 earnings per share for the quarter, beating the consensus estimate of $0.007 by $0.001.

Is Alibaba Health Information Technology Ltd. overvalued?

According to Wall Street analysts Alibaba Health Information Technology Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Alibaba Health Information Technology Ltd. pay dividends?

Alibaba Health Information Technology Ltd. pays a N/A dividend of $0.029 which represents an annual dividend yield of N/A. See more information on Alibaba Health Information Technology Ltd. dividends here

What is Alibaba Health Information Technology Ltd.’s EPS estimate?

Alibaba Health Information Technology Ltd.’s EPS estimate is 0.01.

How many shares outstanding does Alibaba Health Information Technology Ltd. have?

Alibaba Health Information Technology Ltd. has 16,175,301,000 shares outstanding.

What happened to Alibaba Health Information Technology Ltd.’s price movement after its last earnings report?

Alibaba Health Information Technology Ltd. reported an EPS of $0.009 in its last earnings report, beating expectations of $0.007. Following the earnings report the stock price went down -0.688%.

Which hedge fund is a major shareholder of Alibaba Health Information Technology Ltd.?

Currently, no hedge funds are holding shares in ALBHF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Alibaba Health Information Technology Stock Smart Score

Neutral

Fundamentals

Return on Equity

15.30%

Trailing 12-Months

Asset Growth

14.46%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Alibaba Health Information Technology Ltd.

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, medical consultation, appointment-booking, vaccination, dental and mental care, optometry, and nursing services, as well as traditional chinese medicines. The company provides products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Ele.me, AMap, DingTalk, Freshippo, and Quark. In addition, it engages in the digital tracking business; asset management; network hospital, software technical services, healthcare related internet information and technical services and research; operation of internet hospitals, as well as Alibaba Health, flagship platform of Alibaba Group for integrated online and offline medical and healthcare resources, providing one-stop healthcare solutions. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.

Alibaba Health Information Technology (ALBHF) Earnings & Revenues

Historic Earnings Reports

ALBHF Stock 12 Month Forecast

Average Price Target

$0.68

▼(-6.01% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","-1":"-$1","-0.5":"-$0.5","0.5":"$0.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.829504,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$0.83</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.6767294171428572,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$0.68</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.5359872,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$0.54</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.5,0,0.5,1],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.421,0.4524233846153846,0.4838467692307692,0.5152701538461538,0.5466935384615385,0.5781169230769231,0.6095403076923077,0.6409636923076922,0.6723870769230769,0.7038104615384615,0.7352338461538461,0.7666572307692308,0.7980806153846154,{"y":0.829504,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.421,0.4406714936263736,0.46034298725274725,0.48001448087912085,0.4996859745054945,0.5193574681318681,0.5390289617582418,0.5587004553846153,0.578371949010989,0.5980434426373626,0.6177149362637363,0.63738642989011,0.6570579235164835,{"y":0.6767294171428572,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.421,0.4298451692307692,0.43869033846153843,0.44753550769230765,0.45638067692307693,0.46522584615384616,0.4740710153846154,0.4829161846153846,0.4917613538461538,0.5006065230769231,0.5094516923076923,0.5182968615384616,0.5271420307692307,{"y":0.5359872,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.54,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.6,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.671,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.832,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.748,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.71,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.684,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.819,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.691,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.613,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.567,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.486,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.421,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >